David P Walling Selected Research

Therapeutics

1/2024	Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
7/2019	A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
3/2015	Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David P Walling Research Topics

Disease

20	Schizophrenia (Dementia Praecox) 05/2024 - 05/2013
4	Psychotic Disorders (Schizoaffective Disorder) 05/2024 - 03/2015
2	Cognitive Dysfunction 01/2021 - 01/2019
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2015 - 11/2012
1	Nausea 05/2024
1	Constipation 05/2024
1	Major Depressive Disorder (Major Depressive Disorders) 05/2024
1	Vomiting 05/2024
1	Dyspepsia (Indigestion) 05/2024
1	Dystonia (Limb Dystonia) 11/2019
1	Nasopharyngitis 03/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2015
1	Headache (Headaches) 03/2015
1	Weight Gain 05/2013

Drug/Important Bio-Agent (IBA)

7	Antipsychotic Agents (Antipsychotics)IBA 06/2021 - 05/2013
6	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2024 - 05/2013
5	Aripiprazole (Abilify)FDA Link 01/2020 - 05/2013
4	aripiprazole lauroxilIBA 10/2021 - 01/2019
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2021 - 01/2019
3	Paliperidone Palmitate FDA Link 01/2022 - 03/2015
2	2- ((4- (1- methyl- 4- pyridin- 4- yl- 1H- pyrazol- 3- yl)phenoxy)methyl)quinolineIBA 11/2019 - 07/2019
1	AcidsIBA 05/2024
1	xanomelineIBA 05/2024
1	trospium chloride (Ceris)FDA LinkGeneric 05/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2024
1	Cholinergic Agents (Cholinergics)IBA 12/2022
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 06/2021
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2021
1	BI 425809IBA 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	asenapine FDA Link 12/2020
1	BI 409306IBA 01/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2017
1	TabletsIBA 01/2016
1	Antidepressive Agents (Antidepressants)IBA 03/2015
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2015
1	Tryptophan HydroxylaseIBA 02/2015
1	ProdrugsIBA 05/2013
1	pomaglumetad methionilIBA 05/2013
1	4- aminho- 2- thiabicyclo(3.1.0)hexane- 4,6- dicarboxylic acidIBA 05/2013
1	LY 2140023IBA 05/2013
1	Olanzapine (Zyprexa)FDA Link 05/2013
1	Glutamic Acid (Glutamate)FDA Link 05/2013
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2012
1	Serotonin (5 Hydroxytryptamine)IBA 11/2012
1	Mixed Function Oxygenases (Monooxygenases)IBA 11/2012

Therapy/Procedure

6	Injections 01/2024 - 03/2015
3	Therapeutics 01/2024 - 03/2015
2	Ambulatory Care (Outpatient Care) 10/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2021
1	Secondary Prevention 03/2015